help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmid, C.
Right arrow Articles by Froesch, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmid, C.
Right arrow Articles by Froesch, E. R.

Endocrinology, Vol 125, 1575-1580, Copyright © 1989 by Endocrine Society


ARTICLES

Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats

C Schmid, HP Guler, D Rowe and ER Froesch
Department of Medicine (Metabolic Unit), University Hospital, Zurich, Switzerland.

RNA extracted from parietal bones of rats was analyzed for the abundance of type I procollagen mRNA by a dot hybridization assay using specific cDNA probes. Hypophysectomized rats, deficient in IGF I, have 4.1-fold lower steady state levels of mRNA encoding the alpha 1 chain of type I collagen when compared to normal rats of the same weight (120 g). Administration of recombinant human insulin-like growth factor I (IGF I) for 6 days restores bone collagen mRNA levels to normal, and a single sc injection of 100 micrograms IGF I results in a 1.9-fold increase of both alpha 1(I) and alpha 2 (I)chain mRNAs after 8 h. Studies with calvaria cells in primary culture and with a bone-derived cell line, PyMS, yielded similar results: IGF I treatment of these osteoblast-like cells for 24 h increased steady state levels of type I procollagen mRNAs. Thus, IGF I appears to contribute to osteoblast mRNA expression for both chains of type I collagen.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho
Estrogen Regulation of Growth Hormone Action
Endocr. Rev., October 1, 2004; 25(5): 693 - 721.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Endocr. Rev., February 1, 2004; 25(1): 102 - 152.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
T Hytinantti, E-M Rutanen, M Turpeinen, R Sorva, and S Andersson
Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infants
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 17F - 20.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T. L. McCarthy, C. Ji, Y. Chen, K. Kim, and M. Centrella
Time- and Dose-Related Interactions between Glucocorticoid and Cyclic Adenosine 3',5'-Monophosphate on CCAAT/Enhancer-Binding Protein-Dependent Insulin-Like Growth Factor I Expression by Osteoblasts
Endocrinology, January 1, 2000; 141(1): 127 - 137.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Kawane and N. Horiuchi
Insulin-Like Growth Factor I Suppresses Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Expression via a Mitogen-Activated Protein Kinase Pathway in UMR-106 Osteoblast-Like Cells
Endocrinology, February 1, 1999; 140(2): 871 - 879.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Umayahara, C. Ji, M. Centrella, P. Rotwein, and T. L. McCarthy
CCAAT/Enhancer-binding Protein delta  Activates Insulin-like Growth Factor-I Gene Transcription in Osteoblasts. IDENTIFICATION OF A NOVEL CYCLIC AMP SIGNALING PATHWAY IN BONE
J. Biol. Chem., December 12, 1997; 272(50): 31793 - 31800.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, P. Rotwein, and M. Centrella
17beta -Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures
J. Biol. Chem., July 18, 1997; 272(29): 18132 - 18139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Thomas, Y. Umayahara, H. Shu, M. Centrella, P. Rotwein, and T. L. McCarthy
Identification of the cAMP Response Element That Controls Transcriptional Activation of the Insulin-like Growth Factor-I Gene by Prostaglandin E2 in Osteoblasts
J. Biol. Chem., September 6, 1996; 271(36): 21835 - 21841.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Billiard, Y. Umayahara, K. Wiren, M. Centrella, T. L. McCarthy, and P. Rotwein
Regulated Nuclear-Cytoplasmic Localization of CCAAT/ Enhancer-binding Protein delta in Osteoblasts
J. Biol. Chem., April 27, 2001; 276(18): 15354 - 15361.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Billiard, S. S. Grewal, L. Lukaesko, P. J. S. Stork, and P. Rotwein
Hormonal Control of Insulin-like Growth Factor I Gene Transcription in Human Osteoblasts. DUAL ACTIONS OF cAMP-DEPENDENT PROTEIN KINASE ON CCAAT/ENHANCER-BINDING PROTEIN delta
J. Biol. Chem., August 10, 2001; 276(33): 31238 - 31246.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society